References
Schaaf L, Dobbs B, Edwards IR, Perrier D (1987) Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients. Eur J Clin Pharmacol 32: 411–418
Schaaf L, Ferry D, Hung C, Perrier D, Edwards IR (1985) Analysis of 5′-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography. J Chromatogr 342: 303–313
Schaaf L, Dobbs B, Edwards IR, Perrier D (1988) Pharmacokinetics of doxifluridine and 5-fluorouracil after single intravenous infusions of doxifluridine to patients with colorectal cancer. Eur J Clin Pharmacol 34: 439–443
Gibaldi M, Perrier D (1982) Nonlinear pharmacokinetics. In: Swarbrick J (ed) Pharmacokinetics, 2nd edn. Marcel Dekker, New York, pp 271–318
de Bruijn E, van Oosterom A, Tjaden U, Reeuwijk H, Pinedo H (1985) Pharmacology of 5′-deoxy-5-fluorouridine in patients with resistant ovarian cancer. Cancer Res 45: 5931–5935
Diem K, Lentner C (eds) (1970) In: Documenta Geigy, 7th edn. Basle, Ciba Geigy Ltd. Basle, Switzerland
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schaaf, L.J., Dobbs, B.R., Edwards, I.R. et al. The in vitro stability of doxifluridine in whole blood and plasma. Eur J Clin Pharmacol 34, 533–534 (1988). https://doi.org/10.1007/BF01046718
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01046718